Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
girentuximab (5 trials)
felbamate (Felbatol) (2 trials)
gemcitabine (gemzar) (1 trial)
upamostat (2 trials)
capecitabine (xeloda) (1 trial)
wx-037 (1 trial)
wx-uk1 (1 trial)
sunitinib (sutent) (1 trial)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Kidney Neoplasms (Phase 3)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Trials (10 total)
Trial APIs (8 total)